Követés
Joly Yann
Cím
Hivatkozott rá
Hivatkozott rá
Év
The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery
HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ...
Cell 167 (5), 1145-1149, 2016
5652016
The emergence of an ethical duty to disclose genetic research results: international perspectives
BM Knoppers, Y Joly, J Simard, F Durocher
European Journal of Human Genetics 14 (11), 1170-1178, 2006
3342006
Prepublication data sharing
Toronto International Data Release Workshop Authors
Nature 461 (7261), 168-170, 2009
2162009
GA4GH: International policies and standards for data sharing across genomic research and healthcare
HL Rehm, AJH Page, L Smith, JB Adams, G Alterovitz, LJ Babb, ...
Cell genomics 1 (2), 2021
1952021
Genetic discrimination and life insurance: a systematic review of the evidence
Y Joly, I Ngueng Feze, J Simard
BMC medicine 11, 1-15, 2013
1892013
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
M Widschwendter, A Jones, I Evans, D Reisel, J Dillner, K Sundström, ...
Nature reviews Clinical oncology 15 (5), 292-309, 2018
1682018
A review of the key issues associated with the commercialization of biobanks
T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, ...
Journal of Law and the Biosciences 1 (1), 94-110, 2014
1512014
Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO)
Y Joly, ES Dove, BM Knoppers, M Bobrow, D Chalmers
PLoS computational biology 8 (7), e1002549, 2012
1262012
Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers?
MB Forcier, H Gallois, S Mullan, Y Joly
Journal of Law and the Biosciences 6 (1), 317-335, 2019
1222019
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
J Simard, M Dumont, AM Moisan, V Gaborieau, H Vézina, F Durocher, ...
Journal of medical genetics 44 (2), 107-121, 2007
1142007
Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views
G Bertier, M Hétu, Y Joly
BMC medical genomics 9, 1-12, 2016
1102016
Genomic cloud computing: legal and ethical points to consider
ES Dove, Y Joly, AM Tassé, BM Knoppers
European Journal of Human Genetics 23 (10), 1271-1278, 2015
1012015
Ethical issues of CRISPR technology and gene editing through the lens of solidarity
JJ Mulvihill, B Capps, Y Joly, T Lysaght, HAE Zwart, R Chadwick, ...
British medical bulletin 122 (1), 17-29, 2017
982017
Open science versus commercialization: a modern research conflict?
T Caulfield, SHE Harmon, Y Joly
Genome medicine 4, 1-11, 2012
932012
Reflections on the cost of" low-cost" whole genome sequencing: framing the health policy debate
T Caulfield, J Evans, A McGuire, C McCabe, T Bubela, R Cook-Deegan, ...
PLoS biology 11 (11), e1001699, 2013
902013
Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I&I)
JD Brooks, H Nabi, IL Andrulis, AC Antoniou, J Chiquette, P Després, ...
Journal of personalized medicine 11 (6), 511, 2021
882021
Comparative approaches to genetic discrimination: chasing shadows?
Y Joly, IN Feze, L Song, BM Knoppers
Trends in Genetics 33 (5), 299-302, 2017
832017
Genetic discrimination in private insurance: global perspectives
Y Joly, M Braker, M Le Huynh
New genetics and society 29 (4), 351-368, 2010
742010
Life insurance: genomic stratification and risk classification
Y Joly, H Burton, BM Knoppers, IN Feze, T Dent, N Pashayan, ...
European Journal of Human Genetics 22 (5), 575-579, 2014
692014
Looking beyond GINA: policy approaches to address genetic discrimination
Y Joly, C Dupras, M Pinkesz, SA Tovino, MA Rothstein
Annual Review of Genomics and Human Genetics 21 (1), 491-507, 2020
682020
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20